Genetically defined roles of class I, class III, and class IV POU domain factors in the development of the mammalian endocrine and nervous systems

Current Opinion in Endocrinology and Diabetes

Volumn 4, Issue 2, 1997, Pages 172-183

  McEvilly, Robert J ^a   Rosenfeld, Michael G ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001458619     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199704000-00015     Document Type: Article

References (121)

1. Hogan BL: Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996, 10:1580-1594.
2. Roelink H: Tripartite signaling of pattern: interactions between Hedgehogs, BMPs and Wnts in the control of vertebrate development. Curr Opin Neurobiol 1996, 6:33-40.
3. Ericson J, Muhr J, Jessell TM, Edlund T: Sonic hedgehog: a common signal for ventral patterning along the rostrocaudal axis of the neural tube. Int J Dev Biol 1995, 39:809-816.
4. Marshall H, Morrison A, Studer M, Popperl H, Krumlauf R: Retinoids and Hox genes. FASEB J 1996, 10:969-978.
5. Bang AG, Goulding MD: Regulation of vertebrate neural cell fate by transcription factors. Cun Opin Neurobiol 1996, 6:25-32.
6. Lewis J: Neurogenic genes and vertebrate neurogenesis. Curr Opin Neurobiol 1996, 6:3-10.
7. Boncinelli E, Mallamaci A: Homeobox genes in vertebrate gastrulation. Curr Opin Genet Dev 1995, 5:619-627.
8. Rubenstein JLR, Puelles L: Homeobox gene expression during development of the vertebrate brain. Curr Top Dev Biol 1994, 29:1-65.
9. Puelles L, Rubenstein JL: Expression patterns of homeobox and other putative regulatory genes in the embryonic mouse forebrain suggest a neuromeric organization. Trends Neurosci 1993, 16:472-479.
10. Lumsden A, Krumlauf R: Patterning the vertebrate neuraxis. Science 1996, 274:1109-1115.
11. Tanabe Y, Jessell TM: Diversity and pattern in the developing spinal cord. Science 1996, 274:1115-1123.
12. Wilkinson DG: Genetic control of segmentation in the vertebrate hindbrain. Perspect Dev Neurobiol 1995, 3:29-38.
13. Shimamura K, Hartigan DJ, Martinez S, Puelles L, Rubenstein JL: Longitudinal organization of the anterior neural plate and neural tube. Development 1995, 121:3923-3933.
14. Guthrie S. The status of the neural segment. Trends Neurosci 1995, 18:74-79.
15. Bally-Cuif L, Wassef M: Determination events in the nervous system of the vertebrate embryo. Curr Opin Genet Dev 1995, 5:450-458.
16. Rubenstein JL, Martinez S, Shimamura K, Puelles L: The embryonic vertebrate forebrain: the prosomeric model. Science 1994, 266:578-580.
17. Guthrie S: Patterning the hindbrain. Curr Opin Neurobiol 1996, 6:41-48.
18. Treier M, Rosenfeld MG: The hypothalamic-pituitary axis: co-development of two organs. Curr Opin Cell Biol 1996, 8:833-843.
19. Andersen B, Rosenfeld MG: Pit-1 determines cell types during development of the anterior pituitary gland: a model for transcriptional regulation of cell phenotypes in mammalian organogenesis. J Biol Chem 1994, 269:29335-29338.
20. Duband JL, Delannet M, Monier F, Garret S, Desban N: Modulations of cellular interactions during development of the neural crest: role of growth factors and adhesion molecules. Curr Top Microbiol Immunol 1996, 212:207-227.
21. Groves AK, Anderson DJ: Role of environmental signals and transcriptional regulators in neural crest development. Dev Genet 1996, 18:64-72.
22. Lindsay RM: Role of neurotrophins and trk receptors in the development and maintenance of sensory neurons: an overview. Philos Trans R Soc Lond, B Biol Sci 1996, 351:365-373.
23. Sharp ZD, Morgan WW: Brain POU-er. Bioessays 1996, 18:347-350.
24. Bronner-Fraser M: Origins and developmental potential of the neural crest. Exp Cell Res 1995, 218:405-417.
25. Bronner-Fraser M: Patterning of the vertebrate neural crest. Perspect Dev Neurobiol 1995, 3:53-62.
26. Ingraham HA, Chen RP, Mangalam HJ, Elsholtz HP, Flynn SE, Lin CR, Simmons OM, Swanson L, Rosenfeld MG: A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 1988, 55:519-529.
27. Bodner M, Castrillo JL, Theill LE, Deerinck T, Ellisman M, Karin M: The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein. Cell 1988, 55:505-518.
28. Sturm RA, Das G, Herr W: The ubiquitous octamer-binding protein OcM contains a POU domain with a homeo box subdomain. Genes Dev 1988, 2:1582-1599.
29. Clerc RG, Corcoran LM, LeBowitz JH, Baltimore D, Sharp PA: The B-cell-specific Oct-2 protein contains POU box- and homeo box-type domains. Genes Dev 1988, 2:1570-1581.
30. Ko HS, Fast P, McBride W, Staudt LM: A human protein specific for the immunoglobulin octamer DNA motif contains a functional homeobox domain. Cell 1988, 55:135-144.
31. Muller MM, Ruppert S, Schaffner W, Matthias P: A cloned octamer transcription factor stimulates transcription from lymphoid-specific promoters in non-B cells. Nature 1988, 336:544-551.
32. Scheidereit C, Cromlish JA, Gerster T, Kawakami K, Balmaceda CG, Currie RA, Roeder RG: A human lymphoid-specific transcription factor that activates immunoglobulin genes is a homoeobox protein. Nature 1988, 336:551-557.
33. Finney M, Ruvkun G, Horvitz HR: The C. elegans cell lineage and differentiation gene unc-86 encodes a protein with a homeodomain and extended similarity to transcription factors. Cell 1988, 55:757-769.
34. Sturm RA, Herr W: The POU domain is a bipartite DNA-binding structure. Nature 1988, 336:601-604.
35. Herr W, Sturm RA, Clerc RG, Corcoran LM, Baltimore D, Sharp PA, Ingraham HA, Rosenfeld MG, Finney M, Ruvkun G, et al.: The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev 1988, 2:1513-1516.
36. Wegner M, Drolet DW, Rosenfeld MG: POU-domain proteins: structure and function of developmental regulators. Curr Opin Cell Biol 1993, 5:488-498.
37. Rhodes SJ, DiMattia GE, Rosenfeld MG: Transcriptional mechanisms in anterior pituitary cell differentiation. Curr Opin Genet Dev 1994, 4:709-717.
38. He X, Treacy MN, Simmons DM, Ingraham HA, Swanson LW, Rosenfeld MG: Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature 1989, 340:35-41.
39. Verrijzer CP, Van der Vliet PC: POU domain transcription factors. Biochim BiophysActa 1993, 1173:1-21.
40. Monuki ES, Weinmaster G, Kuhn R, Lemke G: SCIP: a glial POU domain gene regulated by cyclic AMP. Neuron 1989, 3:783-793.
41. Suzuki N, Rohdewohld H, Neuman T, Gruss P, Scholer HR: Oct-6: a POU transcription factor expressed in embryonal stem cells and In the developing brain. EMBO J 1990, 9:3723-3732.
42. Meijer D, Graus A, Kraay R, Langeveld A, Mulder MP, Grosveld G: The octamer binding factor Oct6: cDNA cloning and expression in early embryonic cells. Nucleic Acids Res 1990, 18:7357-7365.
43. He X, Gerrero R, Simmons DM, Park RE, Lin CJ, Swanson LW, Rosenfeld MG: Tst-1, a member of the POU domain gene family, binds the promoter of the gene encoding the cell surface adhesion molecule PO. Mol Cell Biol 1991, 11:1739-1744.
44. Zimmerman EC, Jones CM, Fet V, Hogan BL, Magnuson MA: Nucleotide sequence of mouse SCIP cDNA, a POU-domain transcription factor. Nucleic Acids Res 1991, 19:956.
45. Kuhn R, Monuki ES, Lemke G: The gene encoding the transcription factor SCIP has features of an expressed retroposon. Mol Cell Biol 1991, 11:4642-4650.
46. Mathis JM, Simmons DM, He X, Swanson LW, Rosenfeld MG: Brain 4: a novel mammalian POU domain transcription factor exhibiting restricted brain-specific expression. EMBO J 1992, 11:2551-2561.
47. Le Moine C, Young WS III: RHS2, a POU domain-containing gene, and its expression in developing and adult rat. Proc Natl Acad Sci U S A 1992, 89:3285-3289.
48. Hara Y, Rovescalli AC, Kim Y, Nirenberg M: Structure and evolution of four POU domain genes expressed in mouse brain. Proc Natl Acad Sci U S A 1992, 89:3280-3284.
49. Li P, He X, Gerrero MR, Mod M, Aggarwal A, Rosenfeld MG: Spacing and orientation of bipartite DNA-binding motifs as potential functional determinants for POU domain factors. Genes Dev 1993, 7:2483-2496.
50. Sumiyama K, Washio-Watanabe K, Saitou N, Hayakawa T, Ueda S: Class III POU genes: generation of homopolymeric amino acid repeats under QC pressure in mammals. J Mol Evol 1996, 43:170-178.
51. Gerrero MR, McEvilly RJ, Turner E, Lin CR, O'Connell S, Jenne KJ, Hobbs MV, Rosenfeld MG: Brn-3.0: a POU-domain protein expressed in the sensory, immune, and endocrine systems that functions on elements distinct from known octamer motifs. Proc Natl Acad Sci U S A 1993, 90:10841-10845.
52. Turner EE, Jenne KJ, Rosenfeld MG: Brn-3.2: a Brn-3-related transcription factor with distinctive central nervous system expression and regulation by retinoic acid. Neuron 1994, 12:205-218.
53. Xiang M, Zhou L, Macke JP, Yoshioka T, Hendry SH, Eddy RL, Shows TB, Nathans J: The Brn-3 family of POU-domain factors: primary structure, binding specificity, and expression in subsets of retinal ganglion cells and somatosensory neurons. J Neurosci 1995, 15:4762-4785. Reports consensus sequence for class IV DNA response elements as determined by random oligonucleotide site selection and expression patterns for class IV POU domain proteins.
54. Voss JW, Wilson L, Rhodes SJ, Rosenfeld MG: An alternative Pit-1 RNA splicing product reveals modular binding and nonmodular transcriptional activities of the POU-specific domain. Mol Endocrinol 1993, 7:1551-1560.
55. Simmons DM, Voss JW, Ingraham HA, Holloway JM, Broide RS, Rosenfeld MG, Swanson LW: Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev 1990, 4:695-711.
56. Alvarez-Bolado G, Rosenfeld MG, Swanson LW: Model of forebrain regionalization based on spatiotemporal patterns of POU-III homeobox gene expression, birthdates, and morphological features. J Comp Neurol 1995, 355:237-295. Reports detailed analysis of class III POU domain mRNA expression in developing and adult rat brain.
57. Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, O'Connell SM, Gukovsky I, Carriere C, Ryan AK, Miller AP, et al.: Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 1996, 384:327-333. Reports positional cloning of a novel homeodomain gene required for anterior pituitary development and for the initial activation of the Pit-1 gene.
58. Malik KF, Kim J, Hartman AL, Kim P, Young WS III: Binding preferences of the POU domain protein Brain-4: implications for autoregulation. Brain Res Mol Brain Res 1996, 38:209-221. This report examines class III POU domain factor expression in hypothalamic nuclei of the mouse and rat and presents the results of the determination of a class III POU domain consensus DNA binding motif by random oligonucleotide site selection.
59. Schonemann MD, Ryan AK, McEvilly RJ, O'Connell SM, Arias CA, Kalla KA, Li P, Sawchenko PE, Rosenfeld MG: Development and survival of the endocrine hypothalamus and posterior pituitary gland requires the neuronal POU domain factor Brn-2. Genes Dev 1995, 9:3122-3135. Reports the consequences of the deletion of the class III POU domain gene Brn-2 on the development of the mouse neuroendocrine system.
60. Collum RG, Fisher PE, Datta M, Mellis S, Thiele C, Huebner K, Croce CM, Israel MA, Theil T, Moroy T, et al.: A novel POU homeodomain gene specifically expressed in cells of the developing mammalian nervous system. Nucleic Acids Res 1992, 20:4919-4925.
61. Lillycrop KA, Budrahan VS, Lakin ND, Terrenghi G, Wood JN, Polak JM, Latchman DS: A novel POU family transcription factor is closely related to Brn-3 but has a distinct expression pattern in neuronal cells. Nucleic Acids Res 1992, 20:5093-5096.
62. Bhargava AK, Li Z, Weissman SM: Differential expression of four members of the POU family of proteins inactivated and phorbol 12-myristate 13-acetate-treated Jurkat T cells. Proc Natl Acad Sci U S A 1993, 90:10260-10264.
63. Ninkina NN, Stevens GE, Wood JN, Richardson WD: A novel Brn3-like POU transcription factor expressed in subsets of rat sensory and spinal cord neurons. Nucleic Acids Res 1993, 21:3175-3182.
64. Xiang M, Zhou L, Peng YW, Eddy RL, Shows TB, Nathans J: Brn-3b: a POU domain gene expressed in a subset of retinal ganglion cells. Neuron 1993, 11:689-701.
65. Fedtsova NG, Turner EE: Brn-3.0 expression identifies early post-mitotic CNS neurons and sensory neural precursors. Mech Dev 1995, 53:291-304. This study utilized specific antisera and cell labeling methods to determine stage-specific expression of class IV POU protein expression in the rat nervous system.
66. McEvilly RJ, Erkman L, Luo L, Sawchenko PE, Ryan AF, Rosenfeld MG: Requirement for Brn-3.0 in differentiation and survival of sensory and motor neurons. Nature 1996, 384:574-577. This study reports the consequences of the deletion of Brn-3.0 in the mouse nervous system.
67. Erkman L, McEvilly RJ, Luo L, Ryan AK, Hooshmand F, O'Connell SM, Keithley EM, Rapaport DH, Ryan AF, Rosenfeld MG: Role of transcription factors Brn-3.1 and Brn-3.2 in auditory and visual system development. Nature 1996, 381:603-606. This report details the effects of the deletions of Brn-3.1 and Brn-3.2 on the development of the visual and auditory systems in mice.
68. Holloway JM, Szeto DP, Scully KM, Glass CK, Rosenfeld MG: Pit-1 binding to specific DNA sites as a monomer or dimer determines gene-specific use of a tyrosine-dependent synergy domain. Genes Dev 1995, 9:1992-2006. This study examines the nature of Pit-1/estrogen receptor-mediated transcriptional transactration synergy on the prolactin promoter and demonstrates that this activity requires that Pit-1 bind to the promoter as a monomer rather than as a dimer.
69. Ingraham HA, Flynn SE, Voss JW, Albert VR, Kapiloff MS, Wilson L, Rosenfeld MG: The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1-Pit-1 interactions. Cell 1990, 61:1021-1033.
70. Jacobson EM, Li P, Leon-del-Rio A, Rosenfeld MG, Aggarwall AK: Structure of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility. Genes Dev 1997, 11:198-212. Reports the cocrystallization of the Pit-1 POU domain and a cognate DNA response element and the orientation of the Pit-1 dimer on this site.
71. Klemm JD, Rould MA, Aurora R, Herr W, Pabo CO: Crystal structure of the OcM POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell 1994, 77:21-32.
72. Voss JW, Wilson L, Rosenfeld MG: POU-domain proteins Pit-1 and OcM interact to form a heteromeric complex and can cooperate to induce expression of the prolactin promoter. Genes Dev 1991, 5:1309-1320.
73. Bach I, Rhodos SJ, Pearse RV 2nd, Heinzel T, Gloss B, Scully KM, Sawchenko PE, Rosenfeld MG: P-Lim, a LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit-1. Proc Natl Acad Sci U S A 1995, 92:2720-2724.
74. Szeto DP, Ryan AK, O'Connell SM, Rosenfeld MG: P-OTX: a PIT-1-interacting homeodomain factor expressed during anterior pituitary gland development. Proc Natl Acad Sci U S A 1996, 93:7706-7710.
75. Bradford AP, Conrad KE, Wasylyk C, Wasylyk B, Gutierrez-Hartmann A: Functional interaction of c-Ets-1 and GHF-1/Pit-1 mediates Ras activation of pituitary-specific gene expression: mapping of the essential c-Ets-1 domain. Mol Cell Biol 1995, 15:2849-2857.
76. Okazawa H, Imafuku I, Minowa MT, Kanazawa I, Hamada H, Mouradian MM: Regulation of striatal D1A dopamine receptor gene transcription by Brn-4. Proc Natl Acad Sci U S A 1996, 93:11933-11938. This report describes the analysis of DNA response elements in a potential class III target gene capable of mediating transcriptional transactivation by Brn-4 but not by Brn-2.
77. Eisen T, Easty DJ, Bennett DC, Goding CR: The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression. Oncogene 1995, 11:2157-2164.
78. Burbach JP, van Schaick HS, de Bree FM, Lopes da Silva S, Adan RA: Functional domains in the oxytocin gene for regulation of expression and biosynthesis of gene products. Adv Exp Med Biol 1995, 395:9-21.
79. Dawson SJ, Liu YZ, Rodel B, Moroy T, Latchman DS: The ability of POU family transcription factors to activate or repress gene expression is dependent on the spacing and context of their specific response elements. Biochem J 1996, 314:439-443. This study compares the binding of class IV POU proteins to both high- and low-affinity DNA response elements and evaluates the relative transactivating potential of class IV factors on these sites.
80. Budhram-Mahadeo V, Theil T, Morns PJ, Lillycrop KA, Moroy T, Latchman DS: The DNA target site for the Brn-3 POU family transcription factors can confer responsiveness to cyclic AMP and removal of serum in neuronal cells. Nucleic Acids Res 1994, 22:3092-3098.
81. Morris PJ, Theil T, Ring CJ, Lillycrop KA, Moroy T, Latchman DS: The opposite and antagonistic effects of the closely related POU family transcription factors Brn-3a and Brn-3b on the activity of a target promoter are dependent on differences in the POU domain. Mol Cell Biol 1994, 14:6907-6914.
82. Budhram-Mahadeo V, Morris PJ, Lakin ND, Theil T, Ching GY, Lillycrop KA, Moroy T, Liem RK, Latchman DS: Activation of the alpha-internexin promoter by the Brn-3a transcription factor is dependent on the N-terminal region of the protein. J Biol Chem 1995, 270:2853-2858.
83. Theil T, Rödel B, Spiegelhalter F, Möröy T: Short isoform of POU factor Brn-3b can form a heterodimer with Brn-3a that is inactive for octamer motif binding. J Biol Chem 1995, 270:30958-30964. This study documents the DNA-binding abilities of class IV proteins on both high- and low-affinity DNA response elements. The absence of DNA-binding activity for a proposed short form of Brn-3.2 and the ability of this protein to interact in solution with other members of the class IV family are demonstrated.
84. Lakin ND, Morris PJ, Theil T, Sato TN, Möröy T, Wilson MC, Latchman DS: Regulation of neurite outgrowth and SNAP-25 gene expression by the Brn-3a transcription factor. J Biol Chem 1995, 270:15858-15863.
85. Lillycrop KA, Liu YZ, Theil T, Moroy T, Latchman DS: Activation of the herpes simplex virus immediate-early gene promoters by neuronally expressed POU family transcription factors. Biochem J 1995, 307:581-584.
86. Milton NG, Bessis A, Changeux JP, Latchman DS: Differential regulation of neuronal nicotinic acetylcholine receptor subunit gene promoters by Brn-3 POU family transcription factors. Biochem J 1996, 317:419-423.
87. Budhram-Mahadeo V, Morris PJ, Lakin ND, Dawson SJ, Latchman DS: The different activities of the two activation domains of the Brn-3a transcription factor are dependent on the context of the binding site. J Biol Chem 1996, 271:9108-9113.
88. Latchman DS: Activation and repression of gene expression by POU family transcription factors. Philos Trans R Soc Lond B Biol Sci 1996, 351:511-515.
89. Theil T, McLean-Hunter S, Zornig M, Moroy T: Mouse Brn-3 family of POU transcription factors: a new aminoterminal domain is crucial for the oncogenic activity of Brn-3a. Nucleic Acids Res 1993, 21:5921-5929.
90. Milton NG, Bessis A, Changeux JP, Latchman DS: The neuronal nicotinic acetylcholine receptor alpha 2 subunit gene promoter is activated by the Brn-3b POU family transcription factor and not by Brn-3a or Brn-3c. J Biol Chem 1995, 270:15143-15147.
91. Dawson SJ, Morris PJ, Latchman DS: A single amino acid change converts an inhibitory transcription factor into an activator. J Biol Chem 1996, 271:11631-11633. This report shows that a single amino acid change in the POU domain of Brn-3.2 is sufficient to alter the actions of the proposed short form of Brn-3.2 from that of a repressor to that of an activator on low-affinity octamerlike DNA response elements.
92. Liu YZ, Dawson SJ, Latchman DS: Alternative splicing of the Brn-3a and Brn-3b transcription factor RNAs is regulated in neuronal cells. J Mol Neurosci 1996, 7:77-85.
93. Smith MD, Dawson SJ, Latchman DS: Inhibition of neuronal process outgrowth and neuronal specific gene activation by the Brn-3b transcription factor. J Biol Chem 1997, 272:1382-1388.
94. Smith MD, Dawson SJ, Latchman DS: The Brn-3a transcription factor induces neuronal process outgrowth and the coordinate expression of genes encoding synaptic proteins. Mol Cell Biol 1997, 17:345-354.
95. Fujii H, Hamada H: A CNS-specific POU transcription factor, Brn-2, is required for establishing mammalian neural cell lineages. Neuron 1993, 11:1197-1206.
96. Suzuki T, Kim HS, Kurabayashi M, Hamada H, Fujii H, Aikawa M, Watanabe M, Watanabe N, Sakomura Y, Yazaki Y, Nagai R: Preferential differentiation of P19 mouse embryonal carcinoma cells into smooth muscle cells: use of retinoic acid and antisense against the central nervous system-specific POU transcription factor Brn-2. Circ Res 1996, 78:395-404.
97. Angus J, Thomson F, Murphy K, Baker E, Sutherland GR, Parsons PG, Sturm RA: The brn-2 gene regulates the melanocytic phenotype and tumorigenic potential of human melanoma cells. Oncogene 1995, 11:691-700.
98. Smith MD, Latchman DS: The functionally antagonistic POU family transcription factors Brn-3a and Brn-3b show opposite changes in expression during the growth arrest and differentiation of human neuroblastoma cells. Int J Cancer 1996, 67:653-660.
99. Li S, Crenshaw EB 3d, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG: Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 1990, 347:528-533.
100. Lin SC, Li S, Drolet DW, Rosenfeld MG: Pituitary ontogeny of the Snell dwarf mouse reveals Pit-1-independent and Pit-1-dependent origins of the thyrotrope. Development 1994, 120:515-522.
101. Andersen B, Rosenfeld MG: Pit-1 determines cell types during development of the anterior pituitary gland: a model for transcriptional regulation of cell phenotypes in mammalian organogenesis. J Biol Chem 1994, 269:29335-29338.
102. Lin C, Lin SC, Chang CP, Rosenfeld MG: Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth. Nature 1992, 360:765-768.
103. Lin SC, Lin CR, Gukovsky I, Lusis AJ, Sawchenko PE, Rosenfeld MG: Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature 1993, 364:208-213.
104. Chen RP, Ingraham HA, Treacy MN, Albert VR, Wilson L, Rosenfeld MG: Autoregulation of pit-1 gene expression mediated by two cis-active promoter elements. Nature 1990, 346:583-586.
105. Rhodes SJ, Chen R, DiMattia GE, Scully KM, Kalla KA, Lin SC, Yu VC, Rosenfeld MG: A tissue-specific enhancer confers Pit-1-dependent morphogen inducibility and autoregulation on the Pit-1 gene. Genes Dev 1993, 7:913-932.
106. Andersen B, Pearse RV II, Jenne K, Sornson M, Lin SC, Bartke A, Rosenfeld MG: The Ames dwarf gene is required for Pit-1 gene activation. Dev Biol 1995, 172:495-503.
107. Gage PJ, Lossie AC, Scarlett LM, Lloyd RV, Camper SA: Ames dwarf mice exhibit somatotrope commitment but lack growth hormone-releasing factor response. Endocrinology 1995, 136:1161-1167.
108. Gage PJ, Roller ML, Saunders TL, Scarlett LM, Camper SA: Anterior pituitary cells defective in the cell-autonomous factor, df, undergo cell lineage specification but not expansion. Development 1996, 122:151-160.
109. Gage PJ, Brinkmeier ML, Scarlett LM, Knapp LT, Camper SA, Mahon KA: The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage-specific cell proliferation. Mol Endocrinol 1996, 10:1570-1581.
110. Bermingham JR Jr, Scherer SS, O'Connell S, Arroyo E, Kalla KA, Powell FL, Rosenfeld MG: Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and is required for normal respiration. Genes Dev 1996, 10:1751-1762. Reports the consequences of the deletion of the Tst-1/SCIPIOct-6 gene in mice.
111. Jaegle M, Mandemakers W, Broos L, Zwart R, Karis A, Visser P, Grosveld F, Meijer D: The POU factor Oct-6 and Schwann cell differentiation. Science 1996, 273:507-510. Reports the consequences of the deletion of the Tst-1/SCIPIOct-6 gene in mice.
112. Ryan AK, Erkman LE, Bermingham JR, Rosenfeld MG: POU-er-ful developmental regulators revisited. Curr Opin Endocrinol Diabetes 1996, 3:378-387.
113. Nakai S, Kawano H, Yudate T, Nishi M, Kuno J, Nagata A, Jishage K, Hamada H, Fujii H, Kawamura K, et al.: The POU domain transcription factor Brn-2 is required for the determination of specific neuronal lineages in the hypothalamus of the mouse. Genes Dev 1995, 9:3109-3121. Reports the consequences of the deletion of the class III POU domain gene Brn-2 on the development of the mouse neuroendocrine system.
114. Galabov P, Schiebler TH: The ultrastructure of the developing neural lobe. Cell Tissue Res 1978, 189:313-329.
115. Altman J, Bayer SA: The development of the rat hypothalamus. Adv Anat Embryol Cell Biol 1986, 100:1-178.
116. Cunningham ET Jr, Sawchenko PE: Reflex control of magnocellular vasopressin and oxytocin secretion. Trends Neurosci 1991, 14:406-411.
117. de Kok YJ, van der Maarel SM, Bitner-Glindzicz M, Huber I, Monaco AP, Malcolm S, Pembrey ME, Ropers HH, Cremers FP: Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4. Science 1995, 267:685-688. This study reports various mutations in the human Brn-4 gene predicted to abolish DNA binding that are linked to an X-linked deafness condition.
118. Bitner-Glindzicz M, Turnpenny P, Hoglund P, Kaariainen H, Sankila EM, van der Maarel SM, de Kok YJ, Ropers HH, Cremers FP, Pembrey M, et al.: Further mutations in Brain 4 (POU3F4) clarify the phenotype in the X-linked deafness. DFN3. Hum Mol Genet 1995, 4:1467-1469. This study reports additional cases of mutations in the human Brn-4 gene, including an apparent de novo mutation in one daughter that was subsequently inherited together with deafness by her sons.
119. Xiang M, Gan L, Zhou L, Klein WH, Nathans J: Targeted deletion of the mouse POU domain gene Brn-3a causes selective loss of neurons in the brainstem and trigeminal ganglion, uncoordinated limb movement, and impaired suckling. Proc Natl Acad Sci U S A 1996, 93:11950-11955. This study reports the consequences of the deletion of Brn-3.0 in the mouse nervous system.
120. Gan L, Xiang M, Zhou L, Wagner DS, Klein WH, Nathans J: POU domain factor Brn-3b is required for the development of a large set of retinal ganglion cells. Proc Natl Acad Sci U S A 1996, 93:3920-3925. This study reports the effects of Brn-3.2 gene deletion on the development of the mouse visual system.
121. Robinson M, Buj-Bello A, Davies AM: Paracrine interactions of BONF involving NGF-dependent embryonic sensory neurons. Mol Cell Neurosci 1996, 7:143-151.